The DOI matches its Crossref record, with a small difference in title or year.
How receptors turn Ras on
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Sos1 binds strongly to the two SH3 domains of Grb2, which associates with phosphorylated and activated transmembrane signaling receptors through the SH2 domain of Grb2.
“Through the PRD, Sos1 binds strongly to the two SH3 domains of the signaling adaptor Grb2, which associates with phosphorylated and activated transmembrane signaling receptors through the SH2 domain of Grb2.”
From Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice (2016) · cites this paper as McCormick, 1993
Grb2 recruits Sos1 to membrane receptors to mediate Ras activation.
“Thus, Grb2 recruits Sos1 to membrane receptors to mediate Ras activation (McCormick, 1993).”
From Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice (2016) · cites this paper as McCormick, 1993
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 14
- Egan, S. E. et al. Nature 363, 45–51 (1993). · DOI
- Li, N. et al. Nature 363, 85–88 (1993). · DOI
- Gale, N. W., Kaplan, S., Lowenstein, E. J., Schlessinger, J. & Bar-Sagi, D. Nature 363, 88–92 (1993). · DOI
- Rozakis-Adcock, M., Fernley, R., Wade, J., Pawson, T. & Bowtell, D. Nature 363, 83–85 (1993). · DOI
- Simon, M. A., Dodson, G. S. & Rubin, G. M. Cell 73, 169–177 (1993). · DOI
- Olivier, J. P. et al. Cell 73, 179–191 (1993). · DOI
- Buday, L. & Downward, J. Cell 73, 611–620 (1993). · DOI
- Chardin, P. et al. Science (in the press).
- Koch, C. A., Anderson, D., Moran, M. F., Ellis, C. & Pawson, T. Science 252, 668–674 (1991). · DOI
- Mayer, B. & Baltimore, D. Trends Cell Biol. 3, 8–13 (1993). · DOI
- Songyang, Z. et al. Cell 72, 767–778 (1993). · DOI
- Lowenstein, E. J. et al. Cell 70, 431–442 (1992). · DOI
- Cicchetti, P. et al. Science 257, 803–806 (1992). · DOI
- Shou, C., Farnsworth, C. L., Neel, B. G. & Feig, L. A. Nature 358, 351–354 (1992). · DOI
Cited by
Sorted by citations
RAS oncogenes: the first 30 years
Malumbres, M., & Barbacid, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1097 · Cited by 1,902
The discovery of receptor tyrosine kinases: targets for cancer therapy
Gschwind, A., Fischer, O. M., & Ullrich, A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1360 · Cited by 1,227
Lito, P., Pratilas, C. A., Joseph, E. W., Tadi, M., Halilovic, E., Zubrowski, M., Huang, A., Wong, W. L., Callahan, M. K., Merghoub, T., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.10.009 · Cited by 562
Insulin signaling in health and disease
Saltiel, A. R. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142241 · Cited by 446
Wientjes, F. B., Hsuan, J. J., Totty, N. F., & Segal, A. W. (1993) · Biochemical Journal · doi:10.1042/bj2960557 · Cited by 301
The c‐myc Promoter: Still MysterY and Challenge
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(07)99004-1 · Cited by 211
Targeting the mitogen-activated protein kinase pathway: physiological feedback and drug response
Pratilas, C. A., & Solit, D. B. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3064 · Cited by 183
Büscher, D., Hipskind, R. A., Krautwald, S., Reimann, T., & Baccarini, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.466 · Cited by 176
CD28: a signalling perspective
WARD, S. G. (1996) · Biochemical Journal · doi:10.1042/bj3180361 · Cited by 149
Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice
Tao, W., Moore, R., Smith, E. R., & Xu, X.-X. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00129 · Cited by 43
Metadata
- Authors
- McCormick, F.
- Venue
- Nature
- Published
- 1993-05
- Volume
- 363
- Issue
- 6424
- Pages
- 15-16
- ISSN
- 0028-0836
- 1476-4687
- Cited by
- 408
- References
- 0
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review